factual

Moderna repurposed influenza platform for COVID

Moderna had a mRNA influenza vaccine program already built, which allowed the company to swap the influenza sequence for the SARS-CoV-2 sequence quickly, because the surrounding infrastructure was already in place.

factualpending

Speaker

Jeff Coller

Evidence Quote

“Moderna, for example, was testing a vaccine for influenza. That allowed them... to quickly change the influenza sequence out for the COVID sequence”

Source

357 | Jeff Coller on mRNA, Vaccines, and Bespoke Therapeutics— Sean Carroll's Mindscape
Created: 11/17/2026, 7:10:08 AM

Your notes

Loading notes...